2016 AAHKS Annual Meeting

Abstracts Archives

The following abstracts were presented at the podium during the 2016 AAHKS Annual Meeting from November 10-13, 2016 at the Hilton Anatole in Dallas. Download the PDF of the Final Program Book and download the final list of disclosures.

AAHKS Awards

The James A. Rand Young Investigator’s Award

Administrative Claims vs. Surgical Registry: Data Source and Outcome Disparities in Total Joint Arthroplasty
Joseph T. Patterson, MD
Co-Authors: David Sing, BS, Erik Hansen, MD, Bobby Tay, MD and Alan Zhang, MD

The Lawrence D. Dorr Surgical Techniques & Technologies Award

Differences in Post-Operative Outcomes between Total Hip Arthroplasty for Fracture vs. Osteoarthritis
David W. Fitz, MD, Chicago, IL
Co-Authors: Charles Du Qin, BS, Mia Helfrich, BS, Kevin D. Hardt, MD, Matthew D. Beal, MD and David W. Manning, MD

The AAHKS Clinical Research Award

What are the Costs of Knee Osteoarthritis in the Year Prior to TKA?
Nicholas Bedard, MD
Co-Authors: S. Blake Dowdle, MD, Christopher Anthony, MD, David DeMik, PharmD, Michael McHugh, BS, Kevin J. Bozic, MD, MBA and John J. Callaghan, MD

Podium Abstracts in Order of Presentation

      1. Causes and Temporal Distributions of Readmissions after Total Knee Arthroplasty: A Large Database Study
        Robert M. Molloy, MD
      2. Continued Inpatient Care after Primary TKA Increases 30-Day Post-Discharge Complications: A Propensity Score-Adjusted Analysis
        Douglas E. Padgett, MD
      3. Relationship Between Patient Expectations, Patient Satisfaction, and Patient Reported Outcomes in Total Knee Arthroplasty Patients: A Prospective Multi-Center Study
        Deeptee Jain, MD
      4. Administrative Databases Can Yield False Conclusions – An Example of Obesity in Total Joint Arthroplasty
        Jaiben George, MD
      5. A Large 3-Arm RCT: Peripheral Blocks vs. Periarticular Ropivacaine or Liposomal Bupivacaine in TKA
        Matthew P. Abdel, MD
      6. Intraoperative Variability with Load Sensing Technology During Total Knee Arthroplasty
        Alejandro Gonzalez Della Valle, MD
      7. Comparing the Incidence of Patellofemoral Complications in a New Total Knee Arthroplasty (TKA) System vs. Currently Available Products in Two, World-Wide, Multi-Center Prospective Clinical Studies
        Sean D. Toomey, MD
      8. Intra-Articular Injection of an Extended-Release Formulation of Triamcinolone Acetonide Provided Statistically and Clinically Significant Improvement in Pain, Stiffness, and Function in Patients with Knee Osteoarthritis
        Andrew I. Spitzer, MD
      9. Alternative Payment Models Should Risk-Adjust for Conversion Total Hip Arthroplasty: A Propensity Score-Matched Study
        Alexander S. McLawhorn, MD, MBA
      10. Clinical Outcomes and 90-day Costs Following Hemiarthroplasty or Total Hip Arthroplasty for Hip Fracture
        Ryan M. Nunley, MD
      11. Predictors of Discharge to Skilled Nursing Facility (after Primary Total Hip Arthroplasty)
        David C. Ayers, MD
      12. Tranexamic Acid was Safe in Total Hip and Knee Patients with a History of Venous Paper Thromboembolic Events: A Matched Outcome Trial
        Orlando D. Sabbag, MD
      13. Preoperative PROMIS Scores Help Identify Patients Who Will Fail to Improve From Total Hip Arthroplasty at 6 to 12-Month Follow-up
        Benjamin M. Strong, MD
      14. The Impact of Delirium on Perioperative Complications in Primary Total Hip Arthroplasty
        Keith T. Aziz, MD
      15. A Novel Simple Assay to Detect Bacterial Antigen in Synovial Fluid
        Carl A. Deirmengian, MD
      16. The Alpha-Defensin Test Provides Incremental Benefit to the Traditional Tests for Periprosthetic Joint Infection
        Gregory Kazarian, BS
      17. Familial Clustering in Periprosthetic Joint Infection: A Population-Based Cohort Study
        Jeremy M. Gililland, MD
      18. Cost Effectiveness of Staphylococcus Aureus Decolonization Strategies in High-Risk Arthroplasty Patients
        Andy O. Miller, MD
      19. Treatment of Periprosthetic Joint Infection based on Species of Infecting Organism: A Decision Analysis
        Thomas J. Parisi, MD, JD
      20. Comorbidity-Specific Outcomes Differences in Hip Periprosthetic Joint Infection Treatment
        Joseph Kavolus, MD, MSCR
      21. Analysis of Post-Discharge Timing and Risk Factors for Complications in Home-Discharged Primary Total Knee Arthroplasty Patients
        Dong-han Yao, BA
      22. Modifiable Risk Factors in Primary Joint Arthroplasty Increase 90-day Cost of Care
        William C. Schroer, MD
      23. Analysis of Outcomes Following Total Knee Arthroplasty: Do All Databases Produce Similar Findings?
        Nicholas A. Bedard, MD
      24. Can an Arthroplasty Risk Score Predict Bundled Care Events after Total Joint Arthroplasty?
        Blair S. Ashley, MD
      25. Prolonged Conservative Management in Total Joint Arthroplasty: Harming the Patient?
        Carlos J. Lavernia, MD
      26. External Clinical Validation of the “OARA Score” for Outpatient Joint Arthroplasty Candidates
        Michael P. Bolognesi, MD
      27. Preoperative Activity Level Does Not Effect Postoperative Outcomes with a Contemporary Revision Total Knee System
        Kirby D. Hitt, MD
      28. Higher Tissue Concentrations of Vancomycin with Low-dose Intraosseous Regional vs. Intravenous Systemic Prophylaxis in Revision Total Knee Arthroplasty: A Randomized Trial
        Mark J. Spangehl, MD
      29. Porous-Coated Metaphyseal Sleeves for Severe Femoral and Tibial Bone Loss in Revision Total Knee Arthroplasty
        Tyler S. Watters, MD
      30. Revision Total Hip Arthroplasty – Reducing Hospital Cost through Fixed Implant Pricing
        Kristopher D. Collins, MD
      31. The Double Cup Construct: A Novel Treatment Strategy for the Management of Paprosky IIIA and IIIB Acetabular Defects
        Jonathan E. Webb, MD
      32. Outcomes of Modular Dual Mobility Acetabular Components in Revision Total Hip Arthroplasty
        E. Grant Sutter, MD, MS
      33. Patient-reported Allergies: Does the Number of Allergies Affect Outcomes Following Primary Total Hip and Knee Arthroplasty?
        Jesse E. Otero, MD, PhD
      34. Serum Metal Levels for the Diagnosis of Adverse Local Tissue Reaction Secondary to Corrosion in Metal-on-Polyethylene Bearing Total Hip Arthroplasty
        Yale A. Fillingham, MD
      35. History of Beta-Lactam Allergy in Total Joint Patients: Are These Patients Really Allergic?
        Nicolas O. Noiseux, MD
      36. First Time Dislocation Following Total Hip Arthroplasty: What is the Risk of Subsequent Dislocation and Revision?
        Jourdan M. Cancienne, MD
      37. Fewer Complications Following Revision Hip and Knee Arthroplasty in Patients with Normal Vitamin D Levels
        Sophia Traven, MD
      38. Predicting the Incremental Hospital Cost of Adverse Events among Medicare Beneficiaries in the Comprehensive Joint Replacement Program
        David S. Jevsevar, MD
      39. Total Knee Arthroplasty in the 21st Century: Why Do They Fail? A Fifteen-Year Analysis of 11,135 Knees
        Simon W. Young, FRACS
      40. Modified Frailty Index is an Effective Risk Assessment Tool in Primary Total Knee Arthroplasty
        Robert P. Runner, MD
      41. Do Press Ganey Scores Correlate with Total Knee Arthroplasty-Specific Outcome Questionnaires in Post-Surgical Patients?
        Nirav K. Patel, MD, FRCS
      42. Effectiveness of Liposomal Bupivacaine for Postoperative Pain Control in Total Knee Arthroplasty: A Prospective, Randomized, Double Blind, Controlled Trial
        Jeffrey H. DeClaire, MD
      43. Cryoneurolysis for Temporary Relief of Pain Associated with Knee Osteoarthritis: A Multi-center, Prospective, Double-Blind, Randomized, Controlled Trial
        Vinod Dasa, MD
      44. Bariatric Surgery Improves Outcomes After Lower Extremity Arthroplasty in the Morbidly Obese: A Propensity Score-Matched Study
        Ashley E. Levack, MD, MAS
      45. Low Prevalence of Hip and Knee Arthritis in Marathon Runners
        Danielle Y. Ponzio, MD
      46. Preoperative Symptoms in Femoroacetabular Impingement Patients are More Related to Mental Health Scores than the Condition of the Local Tissue
        Cale A. Jacobs, PhD
      47. Long term Results Following the Bernese Periacetabular Osteotomy
        John C. Clohisy, MD
      48. Characterization of Femoral Morphology in the Borderline Dysplastic Hip: Patient-specific 3-D CT Modeling
        Joel E. Wells, MD, MPH
      49. Do Demographic or Arthropometric Factors Affect Tibial Tubercle Lateralization in a Diverse Population? An MRI Study
        Isaac Livshetz, MD
      50. Large Variation in Native Femoral Anteversion in Patients Requiring Total Hip Arthroplasty
        Ed Marel, MBBS, FRACS, FAOrthA
      51. A Large Randomized Clinical Trial of Direct Anterior and Mini-Posterior THA: Which Provides Faster Functional Recovery?
        Michael J. Taunton, MD
      52. Anterior Capsulectomy vs. Repair in Direct Anterior Total Hip Arthroplasty
        Brian M. Curtin, MS, MD
      53. The Impact of Total Hip Arthroplasty on Pelvic Motion and Functional Component Position is Highly Variable
        Denis Nam, MD, MSc
      54. Is There a Threshold Value of Hemoglobin A1c that Predicts Risk of Infection following Primary Total Hip Arthroplasty?
        James A. Browne, MD
      55. Is Orthopaedic Department Teaching Status Associated with Adverse Outcomes of Primary Total Hip Arthroplasty?
        Qais Naziri, MD
      56. Metal Artifact Reduction Sequence MRI Findings in Ceramic-on-Polyethylene Total Hip Arthroplasty
        Jason M. Jennings, MD



Symposium Abstracts in Numeric Order of Presentation

I. Common Hip Arthroplasty Problems: Useful Alternative Solutions
Moderator: Fares Haddad, FRCS
Faculty: Andrew Manktelow, MD, Stephen A. Jones, MD, Jonathan Skinner, FRCS

II. It’s a Brave New World: Alternative Payment Models and Value Creation in Total Joint Replacement
Moderator: Richard Iorio, MD
Faculty: Joseph Bosco, MD, Owen O’Neill, MD, Ryan Nunley, MD, C. Lowry Barnes, MD

III. Current Trends in Multimodal Pain Management for Total Hip and Knee Arthroplasty
Co-branded with American Society of Regional Anesthesia and Pain Medicine
Moderator: William A. Jiranek, MD, FACS
Faculty: Asokumar Buvanendran, MD, Eugene Viscusi, MD, Jeremy A. Ross, MD

V. Understanding Hip Dysplasia: Evolving Disease Concepts and Treatment Innovations
Moderator: John C. Clohisy, MD
Faculty: Paul Beaule, MD, Asheesh Bedi, MD, Christopher L. Peters, MD

VI. Periprosthetic Joint Infection, Practical Guide to Management
Moderator: Javad Parvizi, MD, FRCS
Faculty: Craig J. Della Valle, MD, Thorsten Gherke, MD, Matthew S. Austin, MD

VII. Challenges in Revision Total Knee Arthroplasty: Exposure, Bone Defects Management and Fixation
Moderator: Adolph V. Lombardi, Jr., MD, FACS
Faculty: Edward M. Vasarhelyi, MD, David Lewallen, MD, Michael E. Berend, MD

VIII. Too Loose, Too Tight, Just Right: Total Knee is a Soft Tissue Operation
Moderator: Thomas K. Fehring, MD
Faculty: Douglas A. Dennis, MD, Mark W. Pagnano, MD, Matthew P. Abdel, MD, Thomas P. Vail, MD


Close Bitnami banner